Alterity Therapeutics to Current on the Life Sciences Investor Discussion board

Alterity Therapeutics to Current on the Life Sciences Investor Discussion board

Digital Investor Conferences

MELBOURNE, Australia and SAN FRANCISCO, June 20, 2022 (GLOBE NEWSWIRE) — Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Firm”), a biotechnology firm devoted to growing illness modifying therapies for neurodegenerative ailments, immediately introduced that David Stamler, M.D., Chief Government Officer will current on the Life Sciences Investor Discussion board on Thursday, 23 June 2022 at 8:00 a.m. Pacific Time / 11:00 a.m. Jap Time.

This might be a reside, interactive on-line occasion the place traders are invited to ask the corporate questions in real-time. It is suggested that traders pre-register and run the web system verify to expedite participation and obtain occasion updates. A hyperlink to the registration web page could also be accessed right here and on Alterity’s web site beneath the Traders Part: Occasions and Displays.

If attendees usually are not in a position to be part of the occasion reside on the day of the convention, an archived webcast can even be made out there after the occasion. Be taught extra concerning the occasion at

About Alterity Therapeutics Restricted

Alterity Therapeutics is a scientific stage biotechnology firm devoted to creating an alternate future for folks dwelling with neurodegenerative ailments. The Firm’s lead asset, ATH434, has the potential to deal with numerous Parkinsonian problems. Alterity additionally has a broad drug discovery platform producing patentable chemical compounds to intercede in illness processes. The Firm relies in Melbourne, Australia, and San Francisco, California, USA. For additional info please go to the Firm’s website at

About Digital Investor Conferences®

Digital Investor Conferences (VIC) is the main proprietary investor convention sequence that gives an interactive discussion board for publicly traded corporations to seamlessly current on to traders. Offering a real-time investor engagement answer, VIC is particularly designed to supply corporations extra environment friendly investor entry.  Replicating the elements of an on-site investor convention, VIC affords corporations enhanced capabilities to attach with traders, schedule focused one-on-one conferences and improve their shows with dynamic video content material. Accelerating the subsequent degree of investor engagement, Digital Investor Conferences delivers main investor communications to a world community of retail and institutional traders.

Authorisation & Further info
This announcement was licensed by David Stamler, CEO of Alterity Therapeutics Restricted.

Alterity Therapeutics Investor and Media Contacts:

Rebecca Wilson
[email protected]
+61 417 382 391

Remy Bernarda
[email protected] 
+1 (415) 203-6386

Digital Investor Conferences Contact
John M. Viglotti
SVP Company Providers, Investor Entry
OTC Markets Group
(212) 220-2221
[email protected]